Regulation of 1,25-dihydroxyvitamin D3 receptor gene expression by 1,25-dihydroxyvitamin D3 in the parathyroid in vivo - PubMed (original) (raw)

Regulation of 1,25-dihydroxyvitamin D3 receptor gene expression by 1,25-dihydroxyvitamin D3 in the parathyroid in vivo

T Naveh-Many et al. J Clin Invest. 1990 Dec.

Abstract

1,25-Dihydroxyvitamin D3 (1,25(OH)2D3 dramatically decreases parathyroid hormone (PTH) gene transcription. We have now studied the effect of 1,25(OH)2D3 on the 1,25(OH)2D receptor (VDR) in the parathyroid in vivo. Rats were injected with 1,25(OH)2D3 and the parathyroid-thyroid tissue analyzed for PTHmRNA and VDRmRNA. 1,25(OH)2D3 (50 and 100 pmol ip) decreased PTHmRNA at 6 h with a maximum at 48 h (less than 4% of basal), whereas VDRmRNA was increased only after 6 h with a 1.7-fold increase at 24 h. VDRmRNA levels peaked at 25 pmol 1,25(OH)2D3 with a twofold increase. Serum calcium did not affect VDRmRNA. Parathyroid VDRmRNA ran at 2.2 and 4.4 kb, whereas duodenum VDRmRNA had a single band, all of which increased after 1,25(OH)2D3. Weanling rats on a vitamin D-deficient diet for 3 wk had a more intense 2.2-kb transcript, whereas vitamin D-replete rats had a more intense 4.4-kb band. Dispersed parathyroid-thyroid cells were separated by a flow cytometry (FACS) into a parathyroid cell peak containing PTHmRNA and a second peak with cells positive for thyro-globulin mRNA and calcitonin mRNA. VDRmRNA was concentrated in the parathyroid cell peak. In situ hybridization of parathyroid-thyroid and duodenum for VDRmRNA showed its localization to the parathyroid cells and the duodenal mucosa. Therefore, the VDRmRNA in the parathyroid-thyroid tissue represents predominantly parathyroid cell and not C-cell VDRmRNA which is also a 1,25(OH)2D3 target organ. The increased VDR gene expression in the parathyroid cell would amplify the effect of 1,25(OH)2D3 to decrease PTH gene transcription.

PubMed Disclaimer

Cited by

Parathyroid Cell Proliferation in Secondary Hyperparathyroidism of Chronic Kidney Disease.
Naveh-Many T, Volovelsky O. Naveh-Many T, et al. Int J Mol Sci. 2020 Jun 18;21(12):4332. doi: 10.3390/ijms21124332. Int J Mol Sci. 2020. PMID: 32570711 Free PMC article. Review.
Calcium sensing by endocrine cells.
Brown EM. Brown EM. Endocr Pathol. 2004 Fall;15(3):187-219. doi: 10.1385/ep:15:3:187. Endocr Pathol. 2004. PMID: 15640545 Review.
Arterial calcifications and increased expression of vitamin D receptor targets in mice lacking TIF1alpha.
Ignat M, Teletin M, Tisserand J, Khetchoumian K, Dennefeld C, Chambon P, Losson R, Mark M. Ignat M, et al. Proc Natl Acad Sci U S A. 2008 Feb 19;105(7):2598-603. doi: 10.1073/pnas.0712030105. Epub 2008 Feb 19. Proc Natl Acad Sci U S A. 2008. PMID: 18287084 Free PMC article.
Maternal and Newborn Vitamin D-Binding Protein, Vitamin D Levels, Vitamin D Receptor Genotype, and Childhood Type 1 Diabetes.
Tapia G, Mårild K, Dahl SR, Lund-Blix NA, Viken MK, Lie BA, Njølstad PR, Joner G, Skrivarhaug T, Cohen AS, Størdal K, Stene LC. Tapia G, et al. Diabetes Care. 2019 Apr;42(4):553-559. doi: 10.2337/dc18-2176. Epub 2019 Jan 28. Diabetes Care. 2019. PMID: 30692241 Free PMC article.
PTH and Vitamin D.
Khundmiri SJ, Murray RD, Lederer E. Khundmiri SJ, et al. Compr Physiol. 2016 Mar 15;6(2):561-601. doi: 10.1002/cphy.c140071. Compr Physiol. 2016. PMID: 27065162 Free PMC article. Review.

References

1. Biochem J. 1982 Jul 15;206(1):181-4 - PubMed
1. Proc Natl Acad Sci U S A. 1989 Dec;86(24):9770-3 - PubMed
1. Endocrinology. 1985 Nov;117(5):2203-10 - PubMed
1. Annu Rev Genet. 1985;19:209-52 - PubMed
1. Biochem Biophys Res Commun. 1986 Jun 13;137(2):742-7 - PubMed

Regulation of 1,25-dihydroxyvitamin D3 receptor gene expression by 1,25-dihydroxyvitamin D3 in the parathyroid in vivo - PubMed (original) (raw)